2026年11月2日星期一
M
환우통감
글로벌 속보
Mitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaAI dubbing to help Japanese companies expand global outreach— 日经 Nikkei AsiaIndonesia GDP, US midterm elections, Hong Kong financial summit— 日经 Nikkei AsiaPakistan refineries report 1,860% jump in profit amid war windfall— 日经 Nikkei AsiaAfter US midterms, democracy will face test of ability to self-correct— 日经 Nikkei AsiaThai reformists became too technocratic, party ex-leader Pita says— 日经 Nikkei AsiaJapan bamboo chopsticks catch on in South Korea— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaAI dubbing to help Japanese companies expand global outreach— 日经 Nikkei AsiaIndonesia GDP, US midterm elections, Hong Kong financial summit— 日经 Nikkei AsiaPakistan refineries report 1,860% jump in profit amid war windfall— 日经 Nikkei AsiaAfter US midterms, democracy will face test of ability to self-correct— 日经 Nikkei AsiaThai reformists became too technocratic, party ex-leader Pita says— 日经 Nikkei AsiaJapan bamboo chopsticks catch on in South Korea— 日经 Nikkei Asia

Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders

출처 英国政府公告2일 전
내용 요약

MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.

본 사이트는 제목과 요약 색인만 제공하며, 전체 내용과 저작권은 모두 원 발행처에 있습니다. 원문 링크를 클릭하여 읽어 주세요.

원문 보기
소속 채널
국제
소속 지역
영국
원문 언어
English
항목 번호
world-d38ac368

Comments 0 comments

No comments yet. Be the first.

Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders · 환우통감